Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-08-24
2009-06-23
Shibuya, Mark L (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007910, C435S007920
Reexamination Certificate
active
07550269
ABSTRACT:
A method for the early determination of the risk of death or heart failure in infarction patients, and the risk of death, relapse or complications in ictus patients, the method being based on the determination of PTX3 from plasma or blood.
REFERENCES:
patent: 4208479 (1980-06-01), Zuk et al.
Circulation 2000, vol. 102, p. 636 by Peri et al.
Latini Roberto
Maggioni Aldo P.
Mantovani Alberto
Peri Giuseppi
Cheu Jacob
Shibuya Mark L
Young & Thompson
LandOfFree
PTX3 as an early prognostic indicator of cardiovascular and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PTX3 as an early prognostic indicator of cardiovascular and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PTX3 as an early prognostic indicator of cardiovascular and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4070376